Durable response to afatinib rechallenge in a long‐term survivor of non‐small cell lung cancer harbo...
Durable response to afatinib rechallenge in a long‐term survivor of non‐small cell lung cancer harboring EGFR L858R and L747V mutations
About this item
Full title
Author / Creator
Kanbe, Mio , Sunaga, Noriaki , Hara, Kenichiro , Sawada, Hiiru , Wakamatsu, Ikuo , Hara, Kentaro , Muto, Sohei , Sawada, Yuri , Masubuchi, Hiroaki , Sato, Mari , Miura, Yosuke , Tsurumaki, Hiroaki , Yatomi, Masakiyo , Sakurai, Reiko , Koga, Yasuhiko , Ohtaki, Yoichi , Nagashima, Toshiteru , Okano, Naoko , Kubo, Nobuteru , Maeno, Toshitaka and Hisada, Takeshi
Publisher
Melbourne: Wiley
Journal title
Language
English
Formats
Publication information
Publisher
Melbourne: Wiley
Subjects
More information
Scope and Contents
Contents
Epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors are standard therapeutic agents for non‐small cell lung cancer (NSCLC) patients with major EGFR mutations such as exon 19 deletions and a L858R mutation, whereas treatment strategies for cases with uncommon EGFR mutations remain to be fully established. Here, we report a long‐term (...
Alternative Titles
Full title
Durable response to afatinib rechallenge in a long‐term survivor of non‐small cell lung cancer harboring EGFR L858R and L747V mutations
Authors, Artists and Contributors
Author / Creator
Sunaga, Noriaki
Hara, Kenichiro
Sawada, Hiiru
Wakamatsu, Ikuo
Hara, Kentaro
Muto, Sohei
Sawada, Yuri
Masubuchi, Hiroaki
Sato, Mari
Miura, Yosuke
Tsurumaki, Hiroaki
Yatomi, Masakiyo
Sakurai, Reiko
Koga, Yasuhiko
Ohtaki, Yoichi
Nagashima, Toshiteru
Okano, Naoko
Kubo, Nobuteru
Maeno, Toshitaka
Hisada, Takeshi
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d6b392ec2974405a97ac8b33a3e7d1f8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d6b392ec2974405a97ac8b33a3e7d1f8
Other Identifiers
ISSN
1759-7706,1759-7714
E-ISSN
1759-7714
DOI
10.1111/1759-7714.14678
